Mooshage, Christoph M.
Schimpfle, Lukas
Tsilingiris, Dimitrios
Kender, Zoltan
Aziz-Safaie, Taraneh
Hohmann, Anja
Szendroedi, Julia
Nawroth, Peter
Sturm, Volker
Heiland, Sabine
Bendszus, Martin
Kopf, Stefan
Jende, Johann M. E.
Kurz, Felix T. http://orcid.org/0000-0001-7616-7147
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 1158)
Universitätsklinikum Heidelberg
Article History
Received: 27 July 2023
Accepted: 7 November 2023
First Online: 9 January 2024
Declarations
:
: The Heidelberg University Hospital Ethics Committee approved this retrospective study (28.03.2017, S-383/2016), and all patients gave written informed consent.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.ZK received grants from the German Center of Diabetes Research (DZD); AH received funding from the Medical Faculty of Heidelberg University (Rahel-Straus-Program), JS received grants from the DFG (SFB 1116; SFB 1118), DZD, and the Ministry of Science, Research and the Arts of the State of Baden-Württemberg, travel grants and personal fees from Boehringer Ingelheim Pharma, SHZ received grants from the DFG (TRR 205/2; TRR 333/1; SFB 1231/1; SFB 1118), Ministry of Science, Research and the Arts (DZHK Standortprojekt; DZHK VHB Säule B project; VIP + project MIRANDA), the Helmholtz Association (Helmholtz International Research School for Diabetes), Edith-Haberland-Wagner (EHW) Foundation, Else Kröner-Fresenius-Stiftung (EKFS), PN received grants from the (SFB 1118 and 1158) the DZD, and from Novo Nordisk, SHL received a grant from the Dietmar Hopp Foundation and the DFG (SFB 1118), MB received grants and personal fees from Codman, Guerbet, Bayer, and Novartis, personal fees from Roche, Teva, Springer, Boehringer, Grifols, Braun and grants from the European Union, Siemens, the Dietmar Hopp Foundation, Stryker and the DFG (SFB 1118 and 1158), JJ acknowledges support from the International Foundation for Research in paraplegia (IRP) and the EKFS, FK was supported by the German Research Foundation (KU 3555/1–1, ZH 902/3–1), the Hoffmann-Klose Foundation of Heidelberg University Hospital, and a research grant of Heidelberg University Hospital.